Palisade Bio, Inc. (NASDAQ:PALI – Get Rating) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 116,600 shares, a decrease of 34.8% from the January 31st total of 178,900 shares. Currently, 1.0% of the company’s stock are sold short. Based […]